Sotera Health Price to Book Ratio 2019-2025 | SHC
Historical price to book ratio values for Sotera Health (SHC) over the last 10 years. The current price to book ratio for Sotera Health as of June 20, 2025 is 7.50.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Sotera Health Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-06-20 | 11.39 | 7.81 | |
| 2025-03-31 | 11.66 | $1.46 | 7.99 |
| 2024-12-31 | 13.68 | $1.43 | 9.58 |
| 2024-09-30 | 16.70 | $1.66 | 10.06 |
| 2024-06-30 | 11.87 | $1.49 | 7.95 |
| 2024-03-31 | 12.01 | $1.52 | 7.92 |
| 2023-12-31 | 16.85 | $1.57 | 10.74 |
| 2023-09-30 | 14.98 | $1.34 | 11.22 |
| 2023-06-30 | 18.84 | $1.48 | 12.72 |
| 2023-03-31 | 17.91 | $1.28 | 14.01 |
| 2022-12-31 | 8.33 | $1.24 | 6.72 |
| 2022-09-30 | 6.82 | $2.15 | 3.17 |
| 2022-06-30 | 19.59 | $2.25 | 8.71 |
| 2022-03-31 | 21.66 | $2.27 | 9.54 |
| 2021-12-31 | 23.55 | $2.07 | 11.37 |
| 2021-09-30 | 26.15 | $1.86 | 14.07 |
| 2021-06-30 | 24.23 | $1.85 | 13.10 |
| 2021-03-31 | 24.96 | $1.65 | 15.16 |
| 2020-12-31 | 27.44 | $1.60 | 17.10 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $3.105B | $1.100B |
| Sotera Health Company is a provider of mission-critical end-to-end sterilization solutions and lab testing as well as advisory services for the healthcare industry. The company market through businesses which include Sterigenics(R), Nordion(R) and Nelson Labs(R). Sotera Health Company is Sotera Health Company is based in CLEVELAND. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $139.155B | 26.10 |
| Elevance Health (ELV) | United States | $84.931B | 10.96 |
| CVS Health (CVS) | United States | $84.554B | 10.51 |
| Cencora (COR) | United States | $57.517B | 20.01 |
| Natera (NTRA) | United States | $23.347B | 0.00 |
| DiDi Global (DIDIY) | China | $22.403B | 23.80 |
| Labcorp Holdings (LH) | United States | $21.878B | 17.75 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.676B | 0.00 |
| Solventum (SOLV) | United States | $12.566B | 13.30 |
| CochLear (CHEOY) | Australia | $12.083B | 0.00 |
| ICON (ICLR) | Ireland | $11.595B | 10.78 |
| Revvity (RVTY) | United States | $11.128B | 19.15 |
| Doximity (DOCS) | United States | $10.714B | 49.60 |
| Viatris (VTRS) | United States | $10.293B | 3.54 |
| Avantor (AVTR) | United States | $9.056B | 13.16 |
| HealthEquity (HQY) | United States | $8.820B | 38.64 |
| Medpace Holdings (MEDP) | United States | $8.700B | 23.11 |
| Sonic Healthcare (SKHHY) | Australia | $8.407B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.136B | 13.98 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.085B | 24.06 |
| BrightSpring Health Services (BTSG) | United States | $3.934B | 36.10 |
| Alignment Healthcare (ALHC) | United States | $2.849B | 0.00 |
| Concentras Parent (CON) | United States | $2.676B | 15.47 |
| Organon (OGN) | United States | $2.568B | 2.73 |
| Surgery Partners (SGRY) | United States | $2.542B | 33.06 |
| PACS (PACS) | United States | $2.027B | 0.00 |
| Progyny (PGNY) | United States | $1.856B | 40.85 |
| Ardent Health (ARDT) | United States | $1.854B | 7.90 |
| GeneDx Holdings (WGS) | United States | $1.838B | 70.80 |
| Premier (PINC) | United States | $1.834B | 13.92 |
| GoodRx Holdings (GDRX) | United States | $1.600B | 32.00 |
| Teladoc Health (TDOC) | United States | $1.230B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.147B | 8.73 |
| Establishment Labs Holdings (ESTA) | $1.100B | 0.00 | |
| CareDx (CDNA) | United States | $1.060B | 16.55 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Agilon Health (AGL) | United States | $0.902B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.856B | 8.01 |
| QDM (QDMI) | Hong Kong, SAR China | $0.758B | 0.00 |
| LifeMD (LFMD) | United States | $0.684B | 0.00 |
| Nutex Health (NUTX) | United States | $0.661B | 10.01 |
| Embecta (EMBC) | United States | $0.569B | 3.83 |
| InnovAge Holding (INNV) | United States | $0.512B | 0.00 |
| SBC Medicals (SBC) | United States | $0.482B | 0.00 |
| Enhabit (EHAB) | United States | $0.473B | 38.92 |
| Auna S.A (AUNA) | Luxembourg | $0.459B | 10.33 |
| Sonida Senior Living (SNDA) | United States | $0.454B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.449B | 0.00 |
| Omada Health (OMDA) | $0.399B | 0.00 | |
| Performant Healthcare (PHLT) | United States | $0.267B | 0.00 |
| Oncology Institute (TOI) | United States | $0.212B | 0.00 |
| Beauty Health (SKIN) | United States | $0.184B | 0.00 |
| DocGo (DCGO) | United States | $0.165B | 27.00 |
| Pheton Holdings (PTHL) | China | $0.119B | 0.00 |
| So-Young (SY) | China | $0.102B | 0.00 |
| KindlyMD (NAKA) | United States | $0.084B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.071B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.053B | 0.00 |
| ModivCare (MODV) | United States | $0.052B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.049B | 0.00 |
| Biodesix (BDSX) | United States | $0.040B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.034B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |